Drug Trial Radar · NCT03198728
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
Last checked: Nov 19, 2026Latest source record: Jun 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
314
Actual
Start
Jul 5, 2017
Primary completion
May 1, 2020
Study completion May 1, 2020
Sponsor
- Lead sponsor
- Marius PharmaceuticalsIndustry
- Sponsor type
- Industry
- Collaborators
- Syneos Health
- First posted
- Jun 26, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This will be a randomized, multicenter, open-label, active-controlled, efficacy, and safety study in adult hypogonadal men. The study duration is 12 months (365 days), including a 90-day, open-label efficacy period and a 9-month (275-day) safety evaluation period.
Conditions
- Hypogonadism, Male
Interventions
SOV2012-F1Drug
oral preparation of testosterone undecanoate (TU)
AndroGelDrug
topical testosterone gel 1.62%
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Male Hypogonadal Subjects With Average NaF/EDTA Plasma Total Testosterone (T Cavg) Within the Normal Range Using Oral SOV2012-F1.Time frame: 90 days
Locations
36 sites in 1 country. Site status is shown where the registry gives one.
Central Research Associates, Inc.
Birmingham, Alabama
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama
Coastal Clinical Research, Inc.
Mobile, Alabama
Quality of Life Medical and Research Centers, LLC
Tucson, Arizona
San Diego Sexual Medicine
San Diego, California
South Florida Medical Research
Aventura, Florida
PAB Clinical Research
Brandon, Florida
Innovative Research of West Florida, Inc.
Clearwater, Florida
Jacksonville Impotence Treatment Center
Jacksonville, Florida
Health Awareness, Inc.
Jupiter, Florida
Meridien Research
Lakeland, Florida
My Community Research Center
Miami, Florida
Oviedo Medical Research, LLC
Oviedo, Florida
Meridien Research
St. Petersburg, Florida
Primary Care Research Group
Atlanta, Georgia
Northwest Clinical Trials
Boise, Idaho
Advanced Clinical Research
Meridian, Idaho
Central Kentucky Research Associates
Lexington, Kentucky
Centex Studies, Inc.
Lake Charles, Louisiana
Men's Health Boston
Chestnut Hill, Massachusetts
Quality Clinical Research, Inc.
Omaha, Nebraska
Palm Research Center, Inc.
Las Vegas, Nevada
Accumed Research Associates
Garden City, New York
Manhattan Medical Research Practice, PLLC
New York, New York
Rapha Institute For Clinical Research
Fayetteville, North Carolina
Aventiv Research, Inc.
Columbus, Ohio
Urologic Consultants of SE Pennsylvania
Bala-Cynwyd, Pennsylvania
Coastal Carolina Research Center
Mt. Pleasant, South Carolina
University Diabetes Endocrine Consultants
Chattanooga, Tennessee
Centex Studies, Inc.
Houston, Texas
Pioneer Research Solutions, Inc.
Houston, Texas
Advanced Clinical Research
West Jordan, Utah
Clinical Research Associates of Tidewater
Norfolk, Virginia
National Clinical Research, Inc.
Richmond, Virginia
Rainier Clinical Research Center, Inc.
Renton, Washington
Mid-Columbia Research
Richland, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.